Status:
RECRUITING
Breast Elasticity Imaging During Neoadjuvant Chemotherapy
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
For this study, the investigators propose investigation of a new imaging technique, Harmonic Motion Imaging (HMI), and the evaluation of its potential role in prediction of breast cancer response to n...
Detailed Description
Neoadjuvant chemotherapy (NACT) is the standard of care for treatment of locally advanced breast cancer (LABC) and inflammatory breast cancer, and is recently being used in earlier stage breast cancer...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Women age ≥18
- Deemed eligible to receive neoadjuvant systemic therapy as per the treating physician, with the dose and schedule deemed appropriate by the treating physician.
- Any stage invasive breast cancer provided the primary breast tumor size is ≥ 4 mm
- Exclusion criteria:
- Patient is pregnant or lactating
- Presence of breast implants
- History of laser or radiation therapy to the affected breast
Exclusion
Key Trial Info
Start Date :
June 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04824027
Start Date
June 14 2021
End Date
May 1 2026
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center/NYP
New York, New York, United States, 10032